NCT02209077

Brief Summary

This single-center, prospective, interventional clinical study is conducted to evaluate the repeatability and reproducibility of structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT (Optical Coherence Tomography) device. Data obtained from healthy volunteers in this study are compared to those from a previous, larger healthy volunteer study that was conducted in the United States and Europe (S-2012-1), and data from glaucoma patients are compared to those from the healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 12, 2013

Completed
12 months until next milestone

First Posted

Study publicly available on registry

August 5, 2014

Completed
Last Updated

August 5, 2014

Status Verified

August 1, 2014

Enrollment Period

1 month

First QC Date

August 12, 2013

Last Update Submit

August 1, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reproducibility and repeatability of multiple parameters (measured with OCT in the back of the eye) between different studies and different subject types

    This study is designed to determine optic nerve head structural values such as ONH rim thickness, RNFL thickness values, and macula structural values such as total retinal or ganglion cell layer thickness, as measured using the Spectralis device in a population of either subjects that are determined to be clinically "normal" or "glaucomatous". The expected reproducibility and repeatability are approximately 5% or less of the respective means (coefficients of variation, cov). This study shall result in a 95% confidence interval of the cov estimate not larger than ±1% when all data is pooled (normal and glaucoma cases). Statistical analysis of the measurement values will consist of the computation of mean and standard deviation in repeated examinations with the SPECTRALIS OCT in the normal and glaucomatous population.

    one day

Study Arms (2)

Healthy Volunteers

EXPERIMENTAL

OCT performed to collect data from the back of the eye

Device: OCT performed to collect data from the back of the eye

Glaucoma group

EXPERIMENTAL

OCT performed to collect data from the back of the eye

Device: OCT performed to collect data from the back of the eye

Interventions

comparative retinal parameters with Spectralis OCT

Glaucoma groupHealthy Volunteers

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is not an employee of the eye clinic.
  • Age ≥18
  • Able and willing to undergo the test procedures, give consent, and to follow instructions.
  • For "normal subjects": Healthy eye without prior intraocular surgery (except cataract surgery and Lasik - laser-assisted refractive surgery) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve.
  • For "glaucoma subjects": Early to advanced glaucoma according to existing medical charts.
  • Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.
  • When both eyes are eligible, one randomly selected eye will enter the study.

You may not qualify if:

  • Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:
  • Retina completely included in image frame,
  • Quality Score ≥ 20 in the stored ART mean images

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology and Visual Sciences, Dalhousie University

Halifax, Nova Scotia, B3H 2Y9, Canada

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Balwantray C Chauhan, PhD

    Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2013

First Posted

August 5, 2014

Study Start

June 1, 2013

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

August 5, 2014

Record last verified: 2014-08

Locations